EyePoint Pharmaceuticals, Inc. Annual Selling and Marketing Expense in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
EyePoint Pharmaceuticals, Inc. quarterly/annual Selling and Marketing Expense history and growth rate from 2016 to 2023.
  • EyePoint Pharmaceuticals, Inc. Selling and Marketing Expense for the quarter ending June 30, 2024 was $50K, a 99.1% decline year-over-year.
  • EyePoint Pharmaceuticals, Inc. Selling and Marketing Expense for the twelve months ending June 30, 2024 was $6.71M, a 70.8% decline year-over-year.
  • EyePoint Pharmaceuticals, Inc. annual Selling and Marketing Expense for 2023 was $11.7M, a 54.2% decline from 2022.
  • EyePoint Pharmaceuticals, Inc. annual Selling and Marketing Expense for 2022 was $25.5M, a 7.26% decline from 2021.
  • EyePoint Pharmaceuticals, Inc. annual Selling and Marketing Expense for 2021 was $27.5M, a 8.74% increase from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Annual (USD)
Selling and Marketing Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $11.7M -$13.8M -54.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-08
2022 $25.5M -$2M -7.26% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-08
2021 $27.5M +$2.21M +8.74% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-10
2020 $25.3M -$4.48M -15% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-14
2019 $29.8M +$20.1M +208% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-12
2018 $9.66M +$9.66M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
2017 $0 $0 Jul 1, 2016 Jun 30, 2017 10-KT 2019-03-18
2016 $0 Jul 1, 2015 Jun 30, 2016 10-KT 2019-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.